67
Hispanic
populations
MESA study showed higher
HF incidence in Hispanic
compared with non-Hispanic
White groups (3.5 versus
2.4 per 1000 person-years)
but lower than for African
Americans (4.6/1000 person-
years).
Despite higher rates of
hospitalization for HF
compared with non-Hispanic
Whites, Hispanic patients with
HF have shown lower short-
term mortality rates.
In GWTG, Hispanic patients
with HfpEF had lower
mortality (OR, 0.50; 95% CI,
0.31–0.81) than non-Hispanic
Whites, but this was not the
case for Hispanic patients with
HFrEF (OR, 0.94; 95% CI,
0.62–1.43).
Lower risk of developing AF
in the setting of HF, compared
with White patients.
Asian and
Pacific Islander
populations
Limited population-specific
data for Asian and pacific
Islander subgroups in the
United States.
High rates of preventable HF
hospitalization observed in
some Asian and Pacific Islander
populations.
Lower mortality rates from
HF for Asian subgroups when
listed as the primary cause of
death, compared with non-
Hispanic White groups.
Native
American and
Alaskan Native
populations
Limited population-specific
data, with cardiovascular risk
factor trends best characterized
by the Strong Heart Study and
Strong Heart Family Study,
demonstrating high rates of
hypertension and diabetes.
Limited data suggest HF
mortality rates in American
Indians and Alaska Natives
are similar to those in White
populations.
(cont'd)
Table 27. Risk of HF and Outcomes in Special Populations
Vulnerable
Population Risk of HF HF Outcomes
(cont'd)
